SEQUANA MEDICAL NV (SEQUA.BR) Stock Price & Overview
EBR:SEQUA • BE0974340722
Current stock price
The current stock price of SEQUA.BR is 0.53 EUR. Today SEQUA.BR is up by 1.53%. In the past month the price increased by 3.11%. In the past year, price decreased by -48.54%.
SEQUA.BR Key Statistics
- Market Cap
- 41.112M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.24
- Dividend Yield
- N/A
SEQUA.BR Stock Performance
SEQUA.BR Stock Chart
SEQUA.BR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to SEQUA.BR. When comparing the yearly performance of all stocks, SEQUA.BR is a bad performer in the overall market: 94.93% of all stocks are doing better.
SEQUA.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to SEQUA.BR. SEQUA.BR may be in some trouble as it scores bad on both profitability and health.
SEQUA.BR Earnings
SEQUA.BR Forecast & Estimates
10 analysts have analysed SEQUA.BR and the average price target is 2.14 EUR. This implies a price increase of 304.15% is expected in the next year compared to the current price of 0.53.
For the next year, analysts expect an EPS growth of 81.63% and a revenue growth 782.35% for SEQUA.BR
SEQUA.BR Groups
Sector & Classification
SEQUA.BR Financial Highlights
Over the last trailing twelve months SEQUA.BR reported a non-GAAP Earnings per Share(EPS) of -1.24. The EPS decreased by -32.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -355.86% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SEQUA.BR Ownership
SEQUA.BR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 14.15 | 94.93B | ||
| 2M6 | MEDTRONIC PLC | 13.59 | 91.207B | ||
| SHL | SIEMENS HEALTHINEERS AG | 13.71 | 41.589B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 15.69 | 23.303B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 15.96 | 23.293B | ||
| BIM | BIOMERIEUX | 15.3 | 10.505B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.5 | 3.763B | ||
| DIA | DIASORIN SPA | 15.03 | 3.502B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 14.32 | 2.481B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.63 | 1.8B | ||
| DRW8 | DRAEGERWERK AG | 9 | 1.392B | ||
| ELN | EL.EN. SPA | 17.42 | 1.057B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.52 | 952.8M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About SEQUA.BR
Company Profile
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 48 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
Company Info
IPO: 2019-02-11
SEQUANA MEDICAL NV
Kortrijksesteenweg 1112, Sint-Denijs-Westrem
Ghent OOST-VLAANDEREN BE
Employees: 48
Phone: 3292928065.0
SEQUANA MEDICAL NV / SEQUA.BR FAQ
What does SEQUA do?
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 48 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
What is the current price of SEQUA stock?
The current stock price of SEQUA.BR is 0.53 EUR. The price increased by 1.53% in the last trading session.
What is the dividend status of SEQUANA MEDICAL NV?
SEQUA.BR does not pay a dividend.
What is the ChartMill technical and fundamental rating of SEQUA stock?
SEQUA.BR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Is SEQUANA MEDICAL NV (SEQUA.BR) expected to grow?
The Revenue of SEQUANA MEDICAL NV (SEQUA.BR) is expected to grow by 782.35% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the employee count for SEQUA stock?
SEQUANA MEDICAL NV (SEQUA.BR) currently has 48 employees.
Can you provide the market cap for SEQUANA MEDICAL NV?
SEQUANA MEDICAL NV (SEQUA.BR) has a market capitalization of 41.11M EUR. This makes SEQUA.BR a Nano Cap stock.